Kocsis Béla, Székely Gábor, Pap Lilla, Németh György
Department of Radiotherapy, National Institute of Oncology, Budapest, Hungary.
Strahlenther Onkol. 2003 Dec;179(12):854-9. doi: 10.1007/s00066-003-1102-4.
To assess the prognostic factors and the benefit of introducing head fixation and CT-assisted radiation treatment planning following postoperative radiotherapy in 83 children with medulloblastoma.
In 24 children treated between 1986 and 1994, no head fixation was applied and boost irradiation was not based on individual radiation treatment planning. Since 1995, boost irradiation has been assisted by CT-based individual radiation treatment planning and ORFIT head fixation in 59 patients. The influence of various factors including age, sex, tumor location, extent, type of surgery, risk group, radiation dose to posterior fossa and spinal axis, and the effect of head fixation and CT-assisted radiation treatment planning on 5-year relapse-free and 5-year overall survival was investigated.
Overall and relapse-free survival rates for all 83 patients were 73.5% and 60.7%. Univariate analysis identified metastatic disease (p = 0.034) and the application of head fixation and individual radiation treatment planning (p = 0.013) as significant prognostic factors for overall survival. Relapse-free survival rates were influenced by metastatic disease (p = 0.028) and the application of head fixation and individual radiation treatment planning (p = 0.009). On multivariate analysis, metastatic disease (p = 0.04) and the application of head fixation and individual radiation treatment planning (p = 0.045) were significant factors for overall and relapse-free survival (p = 0.036 and p = 0.041) as well.
Metastatic disease appears to be correlated with a worse prognosis in this analysis. Individual radiation treatment planning and head fixation have a positive impact on survival. For postoperative radiotherapy of the posterior fossa, the application of head fixation and individual CT-based radiation treatment planning is considered indispensable in each case.
评估83例髓母细胞瘤患儿术后放疗引入头部固定和CT辅助放射治疗计划的预后因素及益处。
1986年至1994年间治疗的24例患儿未采用头部固定,且强化照射并非基于个体化放射治疗计划。自1995年起,59例患者的强化照射采用基于CT的个体化放射治疗计划及ORFIT头部固定。研究了包括年龄、性别、肿瘤位置、范围、手术类型、风险组、后颅窝和脊髓轴的放射剂量等各种因素的影响,以及头部固定和CT辅助放射治疗计划对5年无复发生存率和5年总生存率的影响。
83例患者的总生存率和无复发生存率分别为73.5%和60.7%。单因素分析确定转移性疾病(p = 0.034)以及头部固定和个体化放射治疗计划的应用(p = 0.013)为总生存的显著预后因素。无复发生存率受转移性疾病(p = 0.028)以及头部固定和个体化放射治疗计划的应用(p = 0.009)影响。多因素分析显示,转移性疾病(p = 0.04)以及头部固定和个体化放射治疗计划的应用(p = 0.045)也是总生存和无复发生存的显著因素(p = 0.036和p = 0.041)。
在此分析中,转移性疾病似乎与较差的预后相关。个体化放射治疗计划和头部固定对生存有积极影响。对于后颅窝术后放疗,每种情况下应用头部固定和基于CT的个体化放射治疗计划被认为是必不可少的。